Newbridge Financial Services Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Newbridge Financial Services Group's IBB Position: Q3 2025 in Review
Newbridge Financial Services Group sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 91 shares — an estimated $11.5K sold.
Newbridge Financial Services Group first reported a position in IBB in Q3 2020 and held it in 19 quarters. The position peaked at $406K in Q4 2021. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.
- Newbridge Financial Services Group reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
- Newbridge Financial Services Group sold 91 iShares Biotechnology ETF shares in Q3 2025, an estimated $11.5K.
- Newbridge Financial Services Group first reported a position in iShares Biotechnology ETF in Q3 2020 and held it in 19 quarters.
- Newbridge Financial Services Group's iShares Biotechnology ETF position peaked at $406K in Q4 2021.
- 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.
Based on Newbridge Financial Services Group's 13F filing for Q3 2025, filed 13 Nov 2025.